CDTX - Cidara Therapeutics Inc
IEX Last Trade
11.9
-1.050 -8.824%
Share volume: 40,634
Last Updated: Fri 30 Aug 2024 08:59:04 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$12.95
-1.05
-8.11%
Summary score
30%
Profitability
32%
Dept financing
27%
Liquidity
25%
Performance
30%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
31.45%
Return on assets
-18.25%
Return on sales
-249.84%
Return on invested capital
32.27%
Total debt ratio
87.9%
Debt ratio change over timeo
0.28%
Current Ratio
1.61%
Quick Ratio
1.59%
Cash Position Ratio
1.2%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-15.92%
Return on assets
-15.42%
Return on sales
-99.16%
Return on invested capital
25.23%
Total debt ratio
102.66%
Debt ratio change over timeo
5.86%
Current Ratio
1.3%
Quick Ratio
1.22%
Cash Position Ratio
0.99%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
58.08%
Return on assets
-20.28%
Return on sales
-126.33%
Return on invested capital
17.34%
Total debt ratio
133.73%
Debt ratio change over time
15.6%
Current Ratio
0.72%
Quick Ratio
0.6%
Cash Position Ratio
0.44%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-34.34%
Return on assets
-103.46%
Return on sales
-218.48%
Return on invested capital
-90.44%
Total debt ratio
27.55%
Debt ratio change over time
0.28%
Current Ratio
0.74%
Quick Ratio
0.6%
Cash Position Ratio
0.24%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | CDTX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 31.45% | 13.79% | 34.47% | 7.43% |
| Return on assets | -18.25% | 2.76% | 3.15% | 5.62% |
| Return on sales | -249.84% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | 32.27% | 2.36% | 5.39% | 19.77% |
| Profitability | 48% | 42% | 63% | 71% |
| Total debt ratio | 87.9% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | 0.28% | 308.97% | -6.99% | 1.18% |
| Dept financing | 24% | 50% | 25% | 7% |
| Current Ratio | 1.3% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 1.22% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 0.99% | 0.36% | 1.28% | 2.93% |
| Liquididy | 34% | 14% | 33% | 75% |
| Short-term ratios | CDTX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -15.92% | 13.77% | 13.25% | 3.8% |
| Return on assets | -15.42% | 2.43% | 1.89% | 3.09% |
| Return on sales | -99.16% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | 25.23% | 2.14% | 3.39% | 9.18% |
| Profitability | 25% | 67% | 62% | 66% |
| Total debt ratio | 102.66% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | 5.86% | 46.38% | -72.08% | 1.51% |
| Dept financing | 28% | 47% | 23% | 6% |
| Current Ratio | 1.3% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 1.22% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 0.99% | 0.36% | 1.28% | 2.93% |
| Liquididy | 21% | 12% | 31% | 75% |